Onconetics' Convertible Note Round

Onconetics raised a round of funding on October 05, 2017.

Onconetics Pharmaceuticals, Inc. is a spinout pharmaceutical company from UCSF developing the next generation of personalized gene therapies for cancers and other genetic disorders. Onconetics combine…

Articles about Onconetics' Convertible Note Round: